PMV Pharmaceuticals appoints Dr. Eckler to board
- Dr. Matthew Eckler appointed on Oct 1, 2026
- Serves until 2029 Annual Meeting
- Received 84,000 stock options
Every EDGAR filing for PMV Pharmaceuticals, Inc. (PMVP), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Matthew Joseph Eckler, new insider at PMVP
Matthew Joseph Eckler
Ownership stake disclosure by Samsara BioCapital, L.P.
Samsara BioCapital, L.P., filed by
Securities offering
Ownership stake disclosure by Sio Capital Management, LLC (amended)
Sio Capital Management, LLC, filed by
Ownership stake disclosure by ArrowMark Colorado Holdings LLC (amended)
ArrowMark Colorado Holdings LLC, filed by
Laurie Stelzer, insider filing for PMVP
Laurie Stelzer, reporting
Ownership stake disclosure by Euclidean Capital LLC (amended)
Euclidean Capital LLC, filed by
Ownership stake disclosure by Sio Capital Management, LLC (amended)
Sio Capital Management, LLC, filed by
Michael Carulli, insider filing for PMVP
Michael Carulli, reporting
Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
Ownership stake disclosure by ArrowMark Colorado Holdings LLC (amended)
ArrowMark Colorado Holdings LLC, filed by
Ownership stake disclosure by BML Investment Partners, L.P. (amended)
BML Investment Partners, L.P., filed by
Ownership stake disclosure by Sio Capital Management, LLC (amended)
Sio Capital Management, LLC, filed by